Poland – Antineoplastic agents – ONCOLOGICAL DRUGS II
A structured breakdown of scope, eligibility requirements, submission steps, and key conditions — extracted directly from the official notice.
Sign in to unlock Bid Fit & AI Opportunity Intelligence
TenderZenith calculates a personalized qualification score against your company profile and extracts structured intelligence from tender documents with your 7-Day Pro Trial (No Credit Card Required).
Contract Description
1) Part No. 1 – Belantamabu mafodotin - 520 pcs. 2) Part No. 2 – Adagrasib - 60 pcs. 3) Part No. 3 – Toripalimab - 54 pcs. 4) Part No. 4 – Sotorasibum - 25 pcs. 5) Part No. 5 – Sacituzumabum govitecanum - 300 pcs.